Global Aminopyrine API Market Strategic Research Report

Scope of the Report

The global Aminopyrine API market size is predicted to grow from US$ 30.90 million in 2025 to US$ 27.59 million in 2032; it is expected to grow at a CAGR of -1.7% from 2026 to 2032.

Aminopyrine API is a pyrazolone compound and a derivative of phenacetin, which itself also has anti-inflammatory and antipyretic effects. Aminopyrine (Aminophenazone, Amidopyrine, Pyramidon) is a non-narcotic analgesic. While this drug is inexpensive and highly effective, especially in treating rheumatic diseases, it also carries serious side effects, such as agranulocytosis, and in some cases, even fatal ones. In 2025, global Aminopyrine API production reached approximately 2.26 K MT. Global production capacity in 2025 is approximately 3 K MT. Aminopyrine API is a legacy pyrazolone antipyretic/analgesic. Upstream inputs typically include pyrazolone intermediates (e.g., 4-aminoantipyrine), amination/methylation-related reagents, process solvents/catalysts, plus EHS and QA materials. Supply tends to be concentrated among manufacturers capable of compliant large-scale production, including Shandong Xinhua Pharmaceutical Company Limited, Hebei Jiheng Pharmaceutical Co., Ltd, and Wuhan Wuyao. Downstream demand is mainly tied to compound antipyretic/analgesic injections/tablets in jurisdictions where use persists, as well as research/reference-standard channels.

Aminopyrine is a "historical drug" in the antipyretic and analgesic field, but due to its association with serious hematologic adverse reactions (such as agranulocytosis), it has been withdrawn from the market/banned or strictly restricted in most industrialized countries. Therefore, the global demand for aminopyrine API is relatively limited and highly susceptible to policy influences. At present, demand comes more from countries/regions where legal use still exists and from specific combination preparations (such as compound aminopyrine injections/related combination drugs).

Key Questions Addressed in this Report

What is the 10-year outlook for the global Aminopyrine API market?

What factors are driving Aminopyrine API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Aminopyrine API market opportunities vary by end market size?

How does Aminopyrine API break out by Type, by Application?

This report presents a comprehensive overview of the global Aminopyrine API market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 99% and Above
• Below 99%

Segment by Formulation

• Compound Injection
• Tablets
• Others

Segment by Nature of Demand

• Maintenance Demand
• Substitution-constrained Demand
• Non-therapeutic Demand

Segment by Quality & Compliance Tier

• GMP Pharmaceutical Grade
• Technical Grade/Non-Registration Grade

Segment by Application

• Human Use
• Veterinary Use

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Aminopyrine API market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Human Use, Veterinary Use evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact